News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs

NewsTrendsResourcesEventsOutsourcing-Pharma.comOpens in new window

Home
News
Trends
Resources
Events
Outsourcing-Pharma.comOpens in new window

Archives for November 30, 2011

← 2011

Lonza to supply Elan with API for trials of candidate Alzheimer’s disease drug

30-Nov-2011

By Gareth Macdonald

Chemicals supplier Lonza will manufacture the API for a candidate Alzheimer’s disease drug being developed by Elan in an agreement announced yesterday.

Headlines

Alchemab and Lilly collaborate to discover and develop ALS therapies

MaaT Pharma’s microbiome therapy scores phase 3 win

Adcentrx launches Phase 1 study for its next-generation ADC targeting advanced solid tumors

Promotional features

An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market

Paid for and content provided by Scorpius BioManufacturing

Is GMP grade good enough? What mRNA manufacturers need to know when buying raw materials

Paid for and in partnership with Thermo Fisher Scientific - Biosciences

Continuous bioprocessing set to revolutionize cGMP manufacturing of biologics

Paid for and content provided by Just – Evotec Biologics

BioPharma-Reporter

Advertise with us
Apply to reuse our contentOpens in new window
Press Releases - Guidelines
About us
Contact us
Why Register?

Resources

Report a technical problem
Whitelist our newsletters
Help Centre
RSS Feed
Podcast
Archives